Berberine vs Tesofensine
A side-by-side research comparison of Berberine and Tesofensine across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Berberine | Tesofensine |
|---|---|---|
| Full name | Berberine HCl | Tesofensine (Triple Monoamine Reuptake Inhibitor) |
| Category | Weight Management | Weight Management |
| Status | OTC supplement | Phase 3 Clinical Trial |
| Mechanism | Activates AMP-activated protein kinase (AMPK), the cellular energy sensor, improving insulin sensitivity, reducing hepatic glucose production, lowering LDL cholesterol, and favorably shifting the gut microbiome. | Blocks presynaptic reuptake of noradrenaline, dopamine, and serotonin in the hypothalamus, enhancing satiety signaling, reducing food reward, and increasing thermogenesis. |
| Molecular weight | 371.81 Da | 329.4 Da |
| Half-life | ~2.5 hours (poor systemic bioavailability) | 8-10 days |
| Bioavailability | Low (~5%); improved by dihydroberberine or piperine | High (oral ~93%) |
| Typical dose | 500 mg, 2-3x per day | 0.25-0.5 mg |
| Frequency | 2-3x daily with meals | Once daily |
| Route | Oral capsule | Oral |
Berberine reported benefits
- Improved insulin sensitivity
- Lower fasting blood glucose
- Reduced LDL and triglycerides
- AMPK activation (exercise-mimetic)
- Gut microbiome support
- Modest weight/waist reduction
Tesofensine reported benefits
- Significant appetite reduction
- Increased metabolic rate
- Improved satiety signaling
- 10-12% body weight loss
- Oral administration convenience
Related comparisons
Research and educational reference only. Not medical advice.